These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 34162896)
1. Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy. Vakrou S; Liu Y; Zhu L; Greenland GV; Simsek B; Hebl VB; Guan Y; Woldemichael K; Talbot CC; Aon MA; Fukunaga R; Abraham MR Sci Rep; 2021 Jun; 11(1):13163. PubMed ID: 34162896 [TBL] [Abstract][Full Text] [Related]
2. Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy. Vaniya A; Karlstaedt A; Gulkok D; Thottakara T; Liu Y; Fan S; Eades H; Vakrou S; Fukunaga R; Vernon HJ; Fiehn O; Roselle Abraham M J Mol Cell Cardiol Plus; 2024 Jun; 8():. PubMed ID: 39430912 [TBL] [Abstract][Full Text] [Related]
3. Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy. Liu Y; Afzal J; Vakrou S; Greenland GV; Talbot CC; Hebl VB; Guan Y; Karmali R; Tardiff JC; Leinwand LA; Olgin JE; Das S; Fukunaga R; Abraham MR Front Cardiovasc Med; 2019; 6():170. PubMed ID: 31921893 [No Abstract] [Full Text] [Related]
4. Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models. Vakrou S; Fukunaga R; Foster DB; Sorensen L; Liu Y; Guan Y; Woldemichael K; Pineda-Reyes R; Liu T; Tardiff JC; Leinwand LA; Tocchetti CG; Abraham TP; O'Rourke B; Aon MA; Abraham MR JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563334 [TBL] [Abstract][Full Text] [Related]
5. Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy. Schuldt M; Pei J; Harakalova M; Dorsch LM; Schlossarek S; Mokry M; Knol JC; Pham TV; Schelfhorst T; Piersma SR; Dos Remedios C; Dalinghaus M; Michels M; Asselbergs FW; Moutin MJ; Carrier L; Jimenez CR; van der Velden J; Kuster DWD Circ Heart Fail; 2021 Jan; 14(1):e007022. PubMed ID: 33430602 [TBL] [Abstract][Full Text] [Related]
6. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. Crilley JG; Boehm EA; Blair E; Rajagopalan B; Blamire AM; Styles P; McKenna WJ; Ostman-Smith I; Clarke K; Watkins H J Am Coll Cardiol; 2003 May; 41(10):1776-82. PubMed ID: 12767664 [TBL] [Abstract][Full Text] [Related]
7. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy. Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407 [TBL] [Abstract][Full Text] [Related]
8. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784 [TBL] [Abstract][Full Text] [Related]
9. Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Marian AJ Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830 [TBL] [Abstract][Full Text] [Related]
10. Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy. Lucas DT; Aryal P; Szweda LI; Koch WJ; Leinwand LA Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H575-83. PubMed ID: 12414446 [TBL] [Abstract][Full Text] [Related]
11. MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway. Chen P; Li Z; Nie J; Wang H; Yu B; Wen Z; Sun Y; Shi X; Jin L; Wang DW Sci China Life Sci; 2020 Sep; 63(9):1347-1362. PubMed ID: 32207065 [TBL] [Abstract][Full Text] [Related]
12. Carrying both the heterozygous Myh6-R453C and Tnnt2-R92W mutations aggravate the hypertrophic cardiomyopathy phenotype in mice. Lu M; Li S; Han Z; Ma B; Wang L; Wan F; Lei S; Nie Y; Wang J Biochem Biophys Res Commun; 2024 Nov; 733():150582. PubMed ID: 39191188 [TBL] [Abstract][Full Text] [Related]
13. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382 [TBL] [Abstract][Full Text] [Related]
14. Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice. McKee LA; Chen H; Regan JA; Behunin SM; Walker JW; Walker JS; Konhilas JP Arch Biochem Biophys; 2013 Jul; 535(1):39-48. PubMed ID: 23352598 [TBL] [Abstract][Full Text] [Related]
15. Coronary telangiectasia associated with hypertrophic cardiomyopathy. Frustaci A; Lanfranchi G; Bellin M; Chimenti C Eur J Heart Fail; 2012 Dec; 14(12):1332-7. PubMed ID: 22869457 [TBL] [Abstract][Full Text] [Related]
16. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy. Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319 [TBL] [Abstract][Full Text] [Related]